US2022411756A1PendingUtilityA1

Extracellular matrices which can be used as scaffold for living cells

Assignee: UNIV FREIBURG ALBERT LUDWIGSPriority: Oct 25, 2010Filed: Jun 8, 2022Published: Dec 29, 2022
Est. expiryOct 25, 2030(~4.3 yrs left)· nominal 20-yr term from priority
C12N 2533/76C12N 5/0068C12N 5/0655C12N 5/0606C12N 5/0654C12N 2537/00C12N 2533/50C12N 5/0621C12N 2533/70C12N 5/0657C12N 2533/72C12N 5/0679C12N 2533/80C12N 5/0684C12N 2533/74C12N 5/0618C12N 5/0653C12N 5/0662C12N 5/0625C12N 5/0676C12N 5/0696C12N 5/0605C12N 5/0661
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention discloses an extracellular matrix comprising a modified polysaccharide consisting of repeating disaccharide units whereby in at least 11% of the disaccharide units one primary alcohol group is oxidized into a carboxylic acid.

Claims

exact text as granted — not AI-modified
1 - 14 . (canceled) 
     
     
         15 . A material comprising:
 a modified agarose having an at least partial β-sheet structure and comprising repeat disaccharide units, wherein at least 11% of the repeat disaccharide units are carboxylic acids, and wherein the modified agarose has a shear modulus G′ in the range of from 10 Pa to 10 7  Pa.   
     
     
         16 . The material of  claim 15 , wherein 20-90% of the repeat disaccharide units are carboxylic acids. 
     
     
         17 . The material of  claim 15 , wherein 50-95% of the repeat disaccharide units are carboxylic acids. 
     
     
         18 . The material of  claim 15 , wherein the modified agarose further comprises an unmodified polysaccharide. 
     
     
         19 . The material of  claim 18 , wherein the unmodified polysaccharide is selected from the group consisting of agarose, a member of the carrageenan family, hyaluronic acid, heparin sulfate, dermatan sulfate, chondroitin sulfate, alginate, chitosan and pullulan. 
     
     
         20 . The material of  claim 18 , wherein the unmodified polysaccharide comprises agarose. 
     
     
         21 . The material of  claim 18 , wherein the modified agarose is obtained from agarose exhibiting an alpha-helix structure. 
     
     
         22 . The material of  claim 18 , further comprising a peptide sequence covalently coupled to the carboxylic acids. 
     
     
         23 . The material of  claim 18 , further comprising a nucleic acid sequence covalently coupled to the carboxylic acids. 
     
     
         24 . The material of  claim 15 , wherein the material has a shear modulus G′ in the range of from 1 Pa to 100 kPa. 
     
     
         25 . The material of  claim 15 , wherein the material has a shear modulus G′ in the range of from 1 Pa to 50 kPa. 
     
     
         26 . The material of  claim 15 , wherein the material has a shear modulus G′ in the range of from 10 Pa to 10 kPa. 
     
     
         27 . The material of  claim 15 , wherein the material is an implant. 
     
     
         28 . The material of  claim 15 , wherein the material is a regenerative implant. 
     
     
         29 . The material of  claim 30 , wherein the regenerative implant is an artificial skin. 
     
     
         30 . The material of  claim 15 , wherein the material is injectable into a subject. 
     
     
         31 . The material of  claim 15 , wherein the material further comprises living cells. 
     
     
         32 . The material of  claim 15 , wherein the material is implanted as skin in a subject.

Join the waitlist — get patent alerts

Track US2022411756A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.